There have been ground breaking advances in the development and application of molecular diagnostic techniques in all laboratory disciplines. However there are many concerns, common to all disciplines, relating to the use of molecular diagnostics within clinical settings, such as analytical and clinical performance standards, quality control measures, and the paucity of external quality control programs and reference materials. Stringent performance standards in the manufacture and clinical validation of commercial kits, as required by national or international IVD directives, pose additional challenges. The C-MD was convened in part to address some of these concerns, and a number of programs have been formulated.
The general aim of the CMD programs is to promote cooperation and harmonization within the field of Molecular Diagnostics in the laboratory medicine. The general objective is to foster the highest standards in the practice of molecular diagnostics in clinical laboratories.
The C-MD website is primarily targeted at the IFCC community of laboratory professionals, member organisations and corporate members. However, the website may be useful for physicians and other healthcare professionals.
Please see visit following page: /ifcc-scientific-division/sd-committees/c-md/aboutus-c-md/
Dr. Deborah Payne, PhD, D(ABMM), DABCC,
Vice President, Molecular Services
American Pathology Partners
Dr. Parviz Ahmad-Nejad
Helios Klinikum Wuppertal, University Witten/Herdecke
Lehrstul für Mikrobiologie und Laboratoriumsmedizin
Dr. Allen Kwan Chee Chan
Professor of Chemichal Pathology
the Chinese University of Hong Kong
Prof. Masato Maekawa
Department of Laboratory Medicine
Hamamatsu University School of Medicine
Dr. Cyril Mamotte PhD, MAACB, MHGSA,
Director of Research Training
School of Biomedical Sciences
Faculty of Health Sciences
Perth - Australia
Prof. Graciela Russomando
Head of the Department of Molecular Biology and Genetics IICS - UNA
National University of Asuncion